Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Coyle

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Annual Review of Pharmacology and Toxicology|January 25, 2002
Glutamatergic mechanisms in schizophreniaGuochuan Tsai, Joseph T Coyle
Current Medicinal Chemistry|February 7, 2012
NAAG, NMDA receptor and psychosisRichard Bergeron, Joseph T Coyle
Psychopharmacology|June 19, 2004
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophreniaJoseph T Coyle, Guochuan Tsai
International Review of Neurobiology|March 10, 2004
NMDA receptor function, neuroplasticity, and the pathophysiology of schizophreniaJoseph T Coyle, Guochuan Tsai
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapineCecilia Flores, Joseph T Coyle
JAMA Psychiatry|November 8, 2013
Relapse in alcohol use disorder--replyJoseph T Coyle, Dost Ongur
Frontiers in Neuroscience|October 5, 2020
The Discovery and Characterization of Targeted Perikaryal-Specific Brain Lesions With ExcitotoxinsJoseph T Coyle, Robert Schwarcz
JAMA Psychiatry|June 16, 2016
Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance SpectroscopyJoseph T Coyle, Glenn Konopaske
Psychiatry and Clinical Neurosciences|January 23, 2019
Glutamate hypothesis in schizophreniaYota Uno, Joseph T Coyle
Neuron|April 30, 2003
Finding the intracellular signaling pathways affected by mood disorder treatmentsJoseph T Coyle, Ronald S Duman
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Annual Review of Pharmacology and Toxicology|January 25, 2002
Glutamatergic mechanisms in schizophreniaGuochuan Tsai, Joseph T Coyle
Current Medicinal Chemistry|February 7, 2012
NAAG, NMDA receptor and psychosisRichard Bergeron, Joseph T Coyle
Psychopharmacology|June 19, 2004
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophreniaJoseph T Coyle, Guochuan Tsai
International Review of Neurobiology|March 10, 2004
NMDA receptor function, neuroplasticity, and the pathophysiology of schizophreniaJoseph T Coyle, Guochuan Tsai
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapineCecilia Flores, Joseph T Coyle
JAMA Psychiatry|November 8, 2013
Relapse in alcohol use disorder--replyJoseph T Coyle, Dost Ongur
Frontiers in Neuroscience|October 5, 2020
The Discovery and Characterization of Targeted Perikaryal-Specific Brain Lesions With ExcitotoxinsJoseph T Coyle, Robert Schwarcz
JAMA Psychiatry|June 16, 2016
Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance SpectroscopyJoseph T Coyle, Glenn Konopaske
Psychiatry and Clinical Neurosciences|January 23, 2019
Glutamate hypothesis in schizophreniaYota Uno, Joseph T Coyle
Neuron|April 30, 2003
Finding the intracellular signaling pathways affected by mood disorder treatmentsJoseph T Coyle, Ronald S Duman
Pageof 14